Menu Back to Beginning-with-the-End-in-Mind-Study-Endpoints-Targeting-Patient-Centered-Outcomes

Program Committee

  • Elektra Johanna Papadopoulos, MD, MPH
    Elektra Johanna Papadopoulos, MD, MPH Acting Associate Director, Clinical Outcome Assessments Staff, OND, CDER
    FDA, United States
  • Linda S. Deal, MS
    Linda S. Deal, MS Head of Patient-Centered Outcomes Measurement
    Pfizer Inc, United States
  • Dianne  Kennedy, MPH, RPh
    Dianne Kennedy, MPH, RPh Consumer Safety Officer, Study Endpoints and Label Development, CDER
    FDA, United States
  • Annabel  Nixon, PhD
    Annabel Nixon, PhD Director
    Chilli Consultancy, United Kingdom
  • James P. Stansbury, PhD, MPH
    James P. Stansbury, PhD, MPH Social Science Analyst, Division of Non-Prescription Clinical Evaluation, CDER
    FDA, United States
  • Ashley F. Slagle, PhD, MS
    Ashley F. Slagle, PhD, MS Scientific and Regulatory Consultant
    Aspen Consulting, LLC, United States
  • Keith W. Wenzel
    Keith W. Wenzel Senior Director
    Perceptive Partner Program, United States
  • Jessica  Voqui, PharmD, MS
    Jessica Voqui, PharmD, MS Regulatory Review Officer, Study Endpoints and Labeling Development, CDER
    FDA, United States
Load More